Clinical trial
Impact of Anti-static Chamber/Mask
NCT00307970 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00307970 |
|---|---|
| Title | Impact of Anti-static Chamber/Mask |
| Official title | The Impact of an Anti-static Valved-holding Chamber on Bioavailability of Inhaled Fluticasone Propionate in Young Children With Asthma |
| Lead sponsor | University of Florida, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Device, Drug |
| Interventions | HFA FP MDI, conventional chamber/mask, anti-static chamber/mask |
| Enrollment | 12 |
| Start date | Apr 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Mar 28, 2006 |
| Last update posted | Sep 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: